Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke

[1]  D. Wagner,et al.  Validation of an Acute Ischemic Stroke Model: Does Diffusion-Weighted Imaging Lesion Volume Offer a Clinically Significant Improvement in Prediction of Outcome? , 2007, Stroke.

[2]  T. Lehtimäki,et al.  Blood leukocyte count is a risk factor for intima-media thickening and subclinical carotid atherosclerosis in middle-aged men. , 2006, Atherosclerosis.

[3]  D. Krieger,et al.  Statin Use is Independently Associated with Smaller Infarct Volume in Nonlacunar MCA Territory Stroke , 2006, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[4]  S. Grundy,et al.  Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study , 2006, The Lancet.

[5]  Martin Bendszus,et al.  Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization , 2006, Stroke.

[6]  G. Schlaug,et al.  Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk , 2006, Neurology.

[7]  Irene Katzan,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Stroke.

[8]  O. Bang,et al.  Internal and Cortical Border-Zone Infarction: Clinical and Diffusion-Weighted Imaging Features , 2006, Stroke.

[9]  P. Lee,et al.  Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  R. Sacco,et al.  Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality , 2005, Neurology.

[11]  Lynn A Smaha,et al.  The American Heart Association Get With The Guidelines program. , 2004, American heart journal.

[12]  Milind Y Desai,et al.  Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging–Monitored Therapy , 2004, Circulation.

[13]  K. Koh,et al.  Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease. , 2003, International journal of cardiology.

[14]  P. Libby,et al.  Mechanisms of plaque stabilization with statins. , 2003, The American journal of cardiology.

[15]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[16]  A. Hofman,et al.  C-Reactive Protein Predicts Progression of Atherosclerosis Measured at Various Sites in the Arterial Tree: The Rotterdam Study , 2002, Stroke.

[17]  Mark W Parsons,et al.  Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study , 2002, Annals of neurology.

[18]  F. Buonanno,et al.  Acute Ischemic Stroke Patterns in Infective and Nonbacterial Thrombotic Endocarditis: A Diffusion-Weighted Magnetic Resonance Imaging Study , 2002, Stroke.

[19]  F. Buonanno,et al.  Acute Ischemic Stroke Patterns in Infective and Nonbacterial Thrombotic Endocarditis , 2002 .

[20]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[21]  K. Becker.  Targeting the central nervous system inflammatory response in ischemic stroke , 2001, Current opinion in neurology.

[22]  M. Hennerici,et al.  Acute Stroke Patterns in Patients With Internal Carotid Artery Disease: A Diffusion-Weighted Magnetic Resonance Imaging Study , 2001, Stroke.

[23]  H. Naritomi,et al.  Microembolic signals and diffusion-weighted MR imaging abnormalities in acute ischemic stroke. , 2001, AJNR. American journal of neuroradiology.

[24]  R. Sacco,et al.  Elevated White Blood Cell Count and Carotid Plaque Thickness: The Northern Manhattan Stroke Study , 2001, Stroke.

[25]  J. Y. Kim,et al.  Atherothrombotic Middle Cerebral Artery Territory Infarction: Topographic Diversity With Common Occurrence of Concomitant Small Cortical and Subcortical Infarcts , 2000, Stroke.

[26]  J. Alger,et al.  Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. , 2000, Stroke.

[27]  H. A. Smith,et al.  A standardized method for measuring intracranial arterial stenosis. , 2000, AJNR. American journal of neuroradiology.

[28]  G. Schlaug,et al.  Multiple acute stroke syndrome , 2000, Neurology.

[29]  HOMAS,et al.  The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .

[30]  F. Bernini,et al.  HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[31]  J. Pincus.  Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) , 1998, The American journal of cardiology.

[32]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[33]  L. Wilkins.  Large infarcts in the middle cerebral artery territory , 1998, Neurology.

[34]  J. Bogousslavsky,et al.  Large infarcts in the middle cerebral artery territory Etiology and outcome patterns , 1998, Neurology.

[35]  G. Murray,et al.  Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study , 1997, BMJ.

[36]  R. Sacco,et al.  Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. , 1996, The New England journal of medicine.

[37]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[38]  N. Simonian,et al.  Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. , 1996, Stroke.

[39]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[40]  C. Yutani,et al.  Atheromatous embolism in the brain , 1994, Neurology.

[41]  L. Caplan.  Brain embolism, revisited , 1993, Neurology.

[42]  H. Cambon,et al.  Infarcts in the middle cerebral artery territory , 1993, Acta neurologica Scandinavica.

[43]  C. Duyckaerts,et al.  The prevalence of ulcerated plaques in the aortic arch in patients with stroke. , 1992, The New England journal of medicine.

[44]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[45]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.